Table 2. De novo CNVs in OA/TOF patients described in literature.
Cytoband | CNV | Minimum length (bp) | (Candidate) genes | Phenotypes | Reference |
---|---|---|---|---|---|
1q41 | hg19 chr1:g.(?_217879151)_(218010441_?)dup hg19 chr8:g.(?_144940222)_(145060112_?)dup | 131 290 119 890 | SPATA17 PLEC-1, PARP10 | OA, butterfly vertebra, anal atresia without fistula, atrial and ventricular septal defects, bilateral dystopic kidneys, left-sided renal dysplasia | 21 |
2q33.2q35 | hg19 chr2:g.(?_204,394,564)–(219,189,331_?)del | 14 794 767 | MAP2 | OA, agenesis of umbilical artery, multiple brain abnormalities, tapered fingers, clinodactyly of the fifth fingers, deviated feet | 22 |
3q28 | hg19 chr3:g.(?_187913191)_(188468682_?)del | 555 491 | LPP | OA/TOF, tetralogy of Fallot, rib anomalies, hypospadias, small kidneys | 23 |
7q35q36 | hg19 chr7:g.(?_147683847)_(159088636_?)del | 11 404 789 | SHH, MNX1 | Oesophageal stenosis, microcephaly, facial dysmorphism hypoplasia of the lower lumbar vertebrae, lumbosacral hyperlordosis, partial agenesis of sacrum, distended bladder, right ectopic kidney, developmental delay | 24, 25 |
11q13.1q13.2 | hg19 chr11:g.(?_65508902)_(67473140_?)del | 1 964 238 | GSTP1 | OA, facial dysmorphism, developmental delay | 26 |
17q12 | hg19 chr17:g.(?_34727386)_(36297053_?)dup | 1 569 667 | AATF, TADA2L, HNF1B | OA/TOF, anal atresia, sacral bone defect, cryptorchidism | 27 |
20q13.33 | hg19 chr20:g.(?_60238426)_(60895697_?)del | 657 271 | GTPBP5 | OA/TOF, ventricular septal defects, hypospadias, large unilateral hydrocele, large left cystic hygroma | 28 |
Depicted are the few published de novo CNVs in patients with nonsyndromic OA/TOF. Chromosome region according to build hg19.